Drug Search Results
More Filters [+]

Fluphenazine

Alternative Names: fluphenazine, permitil, prolixin, prolixin decanoate, prolixin enanthate
Latest Update: 2024-08-27
Latest Update Note: Clinical Trial Update

Product Description

Fluphenazine is a medication that treats schizophrenia. It is also known as a first generation antipsychotic (FGA) or typical antipsychotic. Fluphenazine rebalances dopamine to improve thinking, mood, and behavior. (Sourced from: https://www.nami.org/About-Mental-Illness/Treatments/Mental-Health-Medications/Types-of-Medication/Fluphenazine-(Prolixin))

Mechanisms of Action: DR Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intramuscular,Oral,Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Bangladesh | Bosnia | Brazil | Bulgaria | Canada | Chile | Colombia | Croatia | Czech | Dominican Republic | Egypt | France | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Italy | Lebanon | Lithuania | Malaysia | Malta | Mexico | Morocco | New Zealand | Pakistan | Peru | Philippines | Portugal | Russia | Serbia | Slovakia | Slovenia | Spain | Sri Lanka | Sweden | Taiwan | Thailand | Turkey | Ukraine | United Kingdom | United States | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fluphenazine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events